Commission Implementing Decision of 26 April 2011 allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134 (notified under document C(2011) 2668)

Subscribe now to view and receive funding opportunities instantlly.

Want another formats or payment options? Call now: +34 91 119 69 77